| Application | Recommended Dilution |
|---|---|
| IF | 1:50-1:200 |
CYBB, also known as NOX2 or gp91-phox, serves as the heavy chain subunit of cytochrome b-558, a critical component of the NADPH oxidase complex in phagocytic cells. This membrane-bound glycoprotein plays an essential role in the respiratory burst that generates reactive oxygen species for microbial killing. Mutations in CYBB are the primary cause of X-linked chronic granulomatous disease, making this target particularly relevant for immunodeficiency research. Beyond its classical role in innate immunity, CYBB has emerged as a significant player in cancer biology and metabolic regulation, where oxidative stress pathways influence tumor microenvironments and cellular metabolism.
This recombinant monoclonal antibody, clone 27A9, offers the reproducibility and consistency that demanding research applications require. Produced using recombinant technology with a defined sequence, this antibody eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. The mouse IgG2a isotype antibody was raised against recombinant human CYBB protein and has been affinity-purified to ensure high specificity for your target.
Validation studies demonstrate effective performance in immunofluorescence applications, with successful staining observed in HeLa cells at dilutions ranging from 1:50 to 1:200. The cytoplasmic and membrane-associated staining pattern observed is consistent with the known subcellular localization of this NADPH oxidase component. The antibody is also validated for ELISA applications, providing flexibility across different experimental workflows.
Whether you are investigating phagocyte function, exploring oxidative stress mechanisms in cancer models, or studying metabolic pathways influenced by reactive oxygen species, this antibody provides a reliable tool for detecting human CYBB in your research.
Email: support@cusabio.com
Distributors Worldwide